Arimidex Reduces Relapse Compared To Tamoxifen, Large Study Reports
New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials
Clinical Trials Approved By NCI In November
Trials Approved In October
Trending Stories
- Before the Olympics were smoke-free, tobacco brand deals ran rampant
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- Jonathan Gerber named chief clinical officer of NYU Langone Health’s Perlmutter Cancer Center
- Tweaking the existing systems is not the answer to drug shortages